Skip to main content
. 2018 Nov 9;10:1758835918807339. doi: 10.1177/1758835918807339

Table 4.

Primary endpoint CNS objective response rate at 12 weeks*.

Phase Ib (n = 5) Phase II (n = 6) Total (n = 11)
Objective response rate, n (%) 2 (40.0%) 1 (16.7%) 3 (27.3%)
 Complete response 0 0 0
 Partial response 2 1 3
*

Evaluable population included eligible patients who received four cycles of treatment and underwent imaging of the brain at week 12.

CNS, central nervous system.